Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastasesNuh N. Rahbari, Dai Fukumura, Christina M. Edrich et al.|Science Translational Medicine|2016Cited by 254
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapyKeehoon Jung, Dai Fukumura, Takahiro Heishi et al.|Journal of Clinical Investigation|2017Cited by 170
Targeting CXCR4-dependent immunosuppressive Ly6C <sup>low</sup> monocytes improves antiangiogenic therapy in colorectal cancerKeehoon Jung, Dai Fukumura, Takahiro Heishi et al.|Proceedings of the National Academy of Sciences|2017Cited by 135